The Elder Care Market: Products and Services

Published by: BCC Research

Published: Jun. 1, 2009 - 213 Pages

Table of Contents

CHAPTER ONE: INTRODUCTION

STUDY GOAL AND OBJECTIVES

REASONS FOR DOING THE STUDY

INTENDED AUDIENCE

SCOPE OF REPORT

METHODOLOGY

INFORMATION SOURCES

AUTHOR’S CREDENTIALS

RELATED BCC PUBLICATIONS

BCC ONLINE SERVICES

DISCLAIMER

CHAPTER TWO: SUMMARY

DECISIVE CHANGES IN LIVES

WHAT DOES THE FUTURE HOLD?

PROJECTIONS FOR FUTURE NEEDS

SUMMARY TABLE PROJECTED NEEDS OF THE U.S. ELDERLY, THROUGH 2014 ($ MILLIONS)

SUMMARY FIGURE PROJECTED NEEDS OF THE U.S. ELDERLY, BY MARKET SEGMENT, 2008-2014 ($ MILLIONS)

SOURCE: BCC RESEARCH

CHAPTER 3: DEMOGRAPHICS OF THE ELDERCARE MARKET

DEFINITIONS

GLOBAL SOCIAL ENVIRONMENT

INTERGENERATIONAL LIVING ISSUES IN DEVELOPING COUNTRIES

INTERGENERATIONAL-LIVING ISSUES IN DEVELOPED COUNTRIES

GLOBAL ECONOMIC ENVIRONMENT

DEMOGRAPHICS IN THE UNITED STATES

SHIFTING DEMOGRAPHICS IN THE U.S

TABLE 1 ESTIMATES FOR OVER-65 POPULATIONS BY U.S. REGION, 2007

RACIAL AND ETHNIC CHANGES

FIGURE 1 DISTRIBUTION OF OVER-65 U.S POPULATION BY RACE/ETHNICITY 2007 AND 2015 (%)

HEALTH OF THE ELDERLY IN THE U.S.

DISCREPANCIES IN MINORITY HEALTH STATUS

LIVING WITH LIMITATIONS

FIGURE 2 PREVALANCE OF CHRONIC CONDITIONS AMONG ADULTS IN THE U.S. OVER 65 YEARS OF AGE, BY RACE AND ETHNICITY (%)

FIGURE 3 CHRONIC CONDITIONS IN U.S. POPULATION OVER 65, 2005 (%)

LONG-TERM CARE SPENDING

FIGURE 4 U.S. NATIONAL SPENDING ON LONG-TERM CARE, BY PAYER, 2005 (%)

U.S. HEALTH TRENDS

TABLE 2 MOST COMMON CHRONIC CONDITIONS BY AGE, GENDER, AND RACE IN U.S., 2005

MORTALITY AND U.S. SENIORS

FIGURE 5 LEADING CAUSES OF U.S. DEATHS IN THOSE OVER 65, 2007 (%)

INDIVIDUAL BEHAVIORS AND MORTALITY

ECONOMIC TRENDS FOR U.S. SENIORS

HOUSING TRENDS FOR U.S. SENIORS

Housing Options

LIFESTYLE TRENDS FOR SENIORS IN THE U.S.

INTERNATIONAL DEMOGRAPHICS

HEALTH OF THE ELDERLY AROUND THE GLOBE

ECONOMIC TRENDS OUTSIDE THE U.S.

HOUSING TRENDS OUTSIDE THE U.S

GLOBAL LIFESTYLE TRENDS OF THE ELDERLY

CHAPTER FOUR: OVERVIEW OF HEALTHCARE FUNDING POSSIBILITIES

U. S. AND INTERNATIONAL HEALTHCARE COSTS

TABLE 3 COMPARISON OF ESTIMATED GOVERNMENT HEALTHCARE SPENDING AS PERCENT OF GDP, 2007 (%/$ MILLIONS))

TABLE 3 (CONTINUED)

FIGURE 6 PROJECTED U.S. POPULATION OVER 65, 2000-2050 (%)

U.S. RETIREMENT FUNDING

Individual Retirement Savings

Social Security

FIGURE 7 RECIPIENTS OF SOCIAL SECURITY BENEFITS, 2006 (%)

Social Security Beneficiaries

Social Security Solvency

Company-sponsored Pension Plans

GLOBAL RETIREMENT FUNDING

Individual Retirement Savings

TABLE 4 SELECTED PUBLIC AND PRIVATE PENSION EXPENDITURES, 2006 ($ MILLIONS)

Social Security

TYPES OF HEALTHCARE FUNDING IN THE U.S

Private Insurance

Long Term Care Insurance

Medicare

Medicare Part A

Medicare Part B

Medicare Part C

Medicare Part D

Medicaid

Medicaid Spending and Community-based Services

TABLE 5 CURRENT MEDICARE/MEDICAID PAYMENTS FOR SERVICES, 2009

TABLE 5 (CONTINUED)

Medicare and Private Health Insurance Reimbursement Issues

Medicare Policies on Reimbursement for Powered Wheelchairs

CHAPTER 5: U.S. GOVERNMENT PROGRAMS AND LEGISLATION FOR THE ELDERLY

THE AMERICANS WITH DISABILITIES ACT

LITIGATION ON BEHALF OF THE ELDERLY

ADDITIONAL LEGISLATION

SAFETY AND QUALITY REGULATIONS

CLASS I AND II DEVICES

NUTRITION PROGRAMS

INFRASTRUCTURE CONSIDERATIONS

CHAPTER 6: INDUSTRY TRENDS BY SECTOR—HEALTHCARE

INDUSTRY TRENDS BY SECTOR—HEALTHCARE

TABLE 6 PROJECTED U.S. MARKET FOR ELDERCARE HEALTHCARE PRODUCTS AND SERVICES, THROUGH 2014 ($ MILLIONS)

ARTHRITIS

TABLE 7 INCIDENCE OF DIAGNOSED ARTHRITIS CASES AND CHRONIC JOINT SYMPTOMS IN THE U.S. BY AGE GROUP, 2006 (MILLION PERSONS)

Current Treatments

Medications

• Rheumatoid Arthritis

• Anticytokine Agents

TABLE 8 NEWER ANTICYTOKINE AGENTS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS

Nutritional Supplements

Future Arthritis Burden in the U.S

FIGURE 8 FUTURE BURDEN OF ARTHRITIS FOR THOSE OVER 65 IN THE U.S., BY GENDER, 2010-2030 (MILLIONS)

Market for Treatments for Arthritis for the Elderly

TABLE 9 PROJECTED U.S. MARKET FOR PHARMACEUTICAL ARTHRITIS MEDICATIONS FOR INDIVIDUALS OVER 65, AT MANUFACTURER’S COST, THROUGH 2014 ($ MILLIONS)

Opportunities for Growth Related to Arthritis

CARDIOVASCULAR DISEASES

Cardiovascular Disease in the U.S.

Cardiovascular Disease Internationally

Risk Factors

Treatments

Lifestyle Changes

Medications

TABLE 10 SELECTED HEART DISEASE MEDICATIONS

TABLE 10 (CONTINUED)

TABLE 11 GLOBAL MARKET FOR CARDIOVASCULAR DISEASE MEDICATIONS, THROUGH 2014 ($ MILLIONS)

TABLE 12 U.S. MARKET FOR CARDIOVASCULAR DISEASE MEDICATIONS FOR THE ELDERLY, THROUGH 2014 ($ MILLIONS)

Surgery

TABLE 13 U.S. MARKET FOR CARDIOVASCULAR SURGICAL PROCEDURES FOR THE ELDERLY, THROUGH 2014 ($ MILLIONS)

NEUROLOGICAL DYSFUNCTIONS

Related Dementias and Alzheimer’s Disease

FIGURE 9 CAUSES OF DEMENTIA IN PEOPLE OVER 65 (%)

Current Treatments for Alzheimer’s

TABLE 14 COMMON PRESCRIPTION MEDICATIONS TO TREAT ALZHEIMER’S DISEASE

DEPRESSION

Origins of the Disease

Genetic Factors

Biological Factors

Sociological Factors

Psychological Factors

Risk Factors for Depression

Gender

Age

Marital status

Family History

Social Support

Family Type

Medical Status

TABLE 15 PERCENTAGE OF PATIENTS WHO REPORT BEING DEPRESSED, BY CHRONIC CONDITION (%)

Types of Depression

Prevalence of the Disorder

Diagnosing Depression

Treatment for Depression

TABLE 16 GLOBAL DIRECT AND INDIRECT COST OF DEPRESSION, THROUGH 2014 ($ MILLIONS)

Therapy

Antidepressant Medications

TABLE 17 SELECTED ANTIDEPRESSANT MEDICATIONS

TABLE 17 (CONTINUED)

• Market for Neurological Medications

TABLE 18 PROJECTED U.S. MARKET FOR DEMENTIA AND DEPRESSION MEDICATIONS FOR THE ELDERLY, THROUGH 2014 ($ MILLIONS)

CANCER

Types of Cancer

FIGURE 10 ESTIMATED NEW CASES OF CANCER IN THE U.S., 2008 (%)

Costs for Cancer

TABLE 19 PROJECTED GLOBAL COSTS FOR CANCER TREATMENTS, THROUGH 2014 ($ MILLIONS)

Treatment for Seniors

TABLE 20 PROJECTED U.S. MARKET FOR ALL TYPES OF CANCER TREATMENTS FOR INDIVIDUALS OVER 65, THROUGH 2014 ($MILLIONS)

DIABETES

Diabetes in the U.S

International Prevalence

Origins of the Disease

Type 2 Diabetes

Complications of Diabetes

Barriers to Care in the U.S.

Diagnosing Diabetes

Prediabetes

Treatment for Type 2 Diabetes

Prescription Trends in Diabetes Care

Medications for Type 2 Diabetes

TABLE 21 SELECTED DIABETIC ORAL AGENTS, BY TYPE, TRADE NAME AND MANUFACTURER

TABLE 21 (CONTINUED)

TABLE 22 GLOBAL MARKET FOR DIABETIC ORAL AGENTS, THROUGH 2014 ($ MILLIONS)

The Elder Market for Diabetic Oral Agents

TABLE 23 U.S. MARKET FOR DIABETIC ORAL AGENTS FOR ADULTS OLDER THAN 65, THROUGH 2014 ($ MILLIONS)

Types of Insulin

Long-acting Insulins

Rapid Insulins

Intermediate-acting Insulin

Short-acting Insulin

TABLE 24 INSULIN MARKET IN U.S. FOR INDIVIDUALS OVER 65, THROUGH 2014 ($ MILLIONS)

Blood Glucose Monitoring

TABLE 25 SELECTED LIST OF COMPANIES MARKETING GLUCOSE MONITORING TESTS

TABLE 26 GLOBAL MARKET FOR BLOOD GLUCOSE MONITORING DEVICES, THROUGH 2014 ($ MILLIONS)

TABLE 27 U.S. BLOOD GLUCOSE MONITORING MARKET THROUGH 2014 ($ MILLIONS)

TABLE 28 GLOBAL BLOOD GLUCOSE MONITORING MARKET FOR INDIVIDUALS OLDER THAN 65, THROUGH 2014 ($ MILLIONS)

TABLE 29 U.S. BLOOD GLUCOSE MONITORING MARKET FOR INDIVIDUALS OLDER THAN 65, THROUGH 2014 ($ MILLIONS)

Rationale for the Use of Blood Glucose Monitors

Nutrition and Exercise

COMMUNICATION DISORDERS

Speech Impairments

Writing Difficulties

Sensory Disabilities

Vision Loss

TABLE 30 PREVALENCE OF AGE-RELATED EYE DISEASES, 2004 (%)

TABLE 30 (CONTINUED)

Eyeglass Market

FIGURE 11 U.S. MARKET FOR EYEGLASSES AND CONTACTS IN 2007 (%)

Market for Vision Loss Products

TABLE 31 PROJECTED U.S. EYEWEAR SALES, THROUGH 2014 ($ MILLIONS)

Market for Eyewear Products for Seniors

TABLE 32 PROJECTED U.S. EYEWEAR SALES FOR INDIVIDUALS OVER 65, THROUGH 2014 ($ MILLIONS)

Cataracts

TABLE 33 PROJECTED COST OF CATARACT SURGERY FOR INDIVIDUALS OVER 65, THROUGH 2014 ($ MILLIONS)

Hearing Loss

TABLE 34 SELECTED HEARING AID MANUFACTURERS

TABLE 35 REPORTED INCIDENCE OF HEARING PROBLEMS AMONG U.S. ADULTS BY SEX/AGE GROUP, 2006 (%)

Projected Senior Market for Hearing Aids

TABLE 36 PROJECTED U.S. MARKET FOR HEARING AIDS FOR INDIVIDUALS OVER 65, AT RETAIL PRICING, THROUGH 2014 ($ MILLIONS)*

Cochlear Implants

Communication Aids

Speech Recognition

Vocal Output Technology

Developments in Communication Technology

Mobile Location Technology

Sensor Technology

Visual and Reading Aids

TABLE 37 2007 VISION AND READING AIDS SALES

Newer adaptive technologies

MEMS-based Hearing Aids

Telephony Accessories

Vision and Reading Aids

Video Magnifiers

ORTHOPEDIC IMPAIRMENTS

TABLE 38 PROJECTED TRENDS IN NUMBER OF U.S. TOTAL HIP AND KNEE REPLACEMENTS, THROUGH 2014 (THOUSANDS OF PROCEDURES)

TABLE 39 U.S. ORTHOPEDIC IMPLANT MARKET BY NUMBER AND TYPE OF PROCEDURE, THROUGH 2014

Orthopedic Implant Market for Elders

TABLE 40 PROJECTED U.S. AND REST OF THE WORLD ORTHOPEDIC IMPLANT MARKET GROWTH, THROUGH 2014 ($ MILLIONS)

TABLE 41 PROJECTED U.S. COSTS OF ORTHOPEDIC SURGERY FOR INDIVIDUALS OVER 65, THROUGH 2014 ($ MILLIONS)

Orthobiologic Market

TABLE 42 GLOBAL ORTHOBIOLOGICS MARKET, BY PRODUCT, THROUGH 2014 ($ MILLIONS)

Orthobiologics and Implications for Falls and the Elderly

RESPIRATORY CONDITIONS

Allergies and Asthma

ASTHMA

Origins of the Disease

Treatments

TABLE 43 SELECTED LIST OF COMMON ALLERGY/ASTHMA MEDICATIONS

TABLE 44 SELECTED LISTING OF INHALED CORTICOSTEROIDS

Costs for Asthma Medications

TABLE 45 GLOBAL COSTS FOR ASTHMA MEDICATIONS FOR INDIVIDUALS OVER 65, THROUGH 2014 ($ MILLIONS)

TABLE 46 U.S. COSTS FOR ASTHMA MEDICATIONS FOR INDIVIDUALS OVER 65, THROUGH 2014 ($ MILLIONS)

CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

Costs of COPD in the U.S,

Home Use of Oxygen and Respiratory Supplies

Costs of Respiratory Care

TABLE 47 PROJECTED COSTS OF HOME OXYGEN AND RESPIRATORY SUPPLIES FOR INDIVIDUALS OVER 65, THROUGH 2014 ($ MILLIONS)

OTHER CHRONIC CONDITIONS

Dental Health

Osteoporosis

Age-related Loss of Strength/Balance/Coordination

UROLOGICAL PROBLEMS

Incontinence Medications

TABLE 48 PROJECTED MARKET FOR INCONTINENCE MEDICATIONS FOR INDIVIDUALS OVER 65, THROUGH 2014 ($ MILLIONS)

Benign Prostatic Hyperplasia (BPH)

TABLE 49 SELECTED MEDICATIONS FOR BPH

TABLE 50 PROJECTED U.S. MARKET FOR BPH MEDICATIONS FOR INDIVIDUALS OVER 65, THROUGH 2014 ($ MILLIONS)

OBESITY

TABLE 51 GLOBAL MARKET FOR PRESCRIPTION WEIGHT LOSS PRODUCTS THROUGH 2014 ($ MILLIONS)

CHAPTER 7: INDUSTRY TRENDS BY SECTOR—HOUSING/PERSONAL CARE

TABLE 52 PROJECTED HOUSING MARKETS FOR SENIORS OVER 65, THROUGH 2014 ($ MILLIONS)

OPTIONS FOR HOUSING

REMODELING TO REMAIN AT HOME

TABLE 53 PROJECTED SPENDING ON HOME RENOVATION PROJECTS BY INDIVIDUALS OVER 65, THROUGH 2014 ($ MILLIONS)

COSTS OF AT-HOME SENIOR SERVICES CARE

TABLE 54 AVERAGE ANNUAL COST OF HOME CARE SERVICES, 2008 ($)

TABLE 55 PROJECTED MARKET FOR HOME CARE SERVICES, THROUGH 2014 ($ MILLIONS)

ADULT DAY CENTERS

ALTERNATIVE COMMUNITIES

Independent Living Communities

Recreationally Based Retirement Communities

Assisted Living

Costs for Assisted Living

TABLE 56 PROJECTED GROWTH OF ASSISTED-LIVING COSTS IN THE U.S. FOR INDIVIDUALS OVER 65, THROUGH 2014 ($ MILLIONS)

Nursing Care

Paying for Skilled Nursing Services

TABLE 57 PROJECTED MARKET FOR SKILLED NURSING FACILITIES FOR INDIVIDUALS OVER 65, THROUGH 2014 ($ MILLIONS)

Alzheimer’s Care

Costs of Alzheimer’s Care

UNPAID CAREGIVERS

PAID CAREGIVERS

Toll on Caregivers

LONG-TERM CARE

FIGURE 12 PROJECTED LIFETIME LONG-TERM CARE NEEDS FOR INDIVIDUALS OVER 65 (%)

END-OF-LIFE CONSIDERATIONS

Legal Matters

Hospice and Alzheimer’s

Hospice Costs and Alzheimer’s Disease

MARKET OPPORTUNITIES IN ELDERCARE HOME SERVICES AND HOUSING OPTIONS

Market Opportunities in …(Continued)

CHAPTER EIGHT: INDUSTRY TRENDS BY SECTOR—ASSISTIVE TECHNOLOGY

TABLE 58 PROJECTED U.S. ASSISTIVE TECHNOLOGY SALES FOR THE ELDERCARE MARKET, THROUGH 2014 ($ MILLIONS)

HOME SAFETY PRODUCTS/SERVICES

ACTIVITY LOCATION/PERSONAL MONITORING AIDS

Activity/Emergency Location Monitors

Remote Medical Monitors

TABLE 59 SELECTED MEDICAL/PERSONAL MONITORING AID MANUFACTURERS

MARKET GROWTH

TABLE 60 PROJECTED U.S. SALES OF MEDICAL/PERSONAL MONITORING AIDS FOR INDIVIDUALS OVER 65, THROUGH 2014 ($ MILLIONS)

MARKET DRIVERS

Market Fragmentation

DAILY LIVING AIDS

TABLE 61 SELECTED DAILY LIVING AIDS MANUFACTURERS

FIGURE 13 DAILY LIVING MARKET, BY SEGMENT AND TOTAL PERCENT OF SALES, 2007 (%)

FIGURE 14 PERCENT OF TOTAL SALES FOR OTHER DAILY LIVING AIDS, 2007 (%)

The Market for Daily Living Aids

TABLE 62 PROJECTED U.S. SALES OF DAILY LIVING AIDS FOR INDIVIDUALS OVER 65, THROUGH 2014 ($ MILLIONS)

Market Share by Company

TABLE 63 DAILY LIVING AIDS MANUFACTURERS, SALES AND PERCENT OF MARKET, 2007 ($ MILLIONS/PERCENT)

Incontinence Product Market

TABLE 64 PROJECTED U.S. SALES OF INCONTINENCE AND OSTOMY PRODUCTS, THROUGH 2014 ($ MILLIONS)

BATHING AIDS

Commode and Shower Chairs

TABLE 65 PROJECTED U.S. SALES OF COMMODE AND SHOWER CHAIRS TO INDIVIDUALS OVER 65, THROUGH 2014 ($ MILLIONS)

MOBILITY AIDS

TABLE 66 REPORTED INCIDENCE OF IMPAIRED MOBLITY AND DEXTERITY IN THE U.S. BY SEX/AGE GROUP, 2006 (%)

TABLE 67 PROJECTED U.S. MARKET FOR MOBILITY PRODUCTS FOR INDIVIDUALS OVER 65, THROUGH 2014 ($ MILLIONS)

AMBULATORY AIDS

TABLE 68 SELECTED AMBULATORY AID MANUFACTURERS

Ambulatory Aids Usage and Demographics

TABLE 69 PROJECTED U.S. SALES OF AMBULATORY AIDS FOR INDIVIDUALS OVER 65, THROUGH 2014 ($ MILLIONS)

WHEELCHAIR/SCOOTER USE

Medicare Reimbursement for Powered Wheelchairs

MARKET SHARE LEADERS

TABLE 70 SELECTED LIST OF WHEELCHAIR AND SCOOTER MANUFACTURERS

TABLE 70 (CONTINUED)

TABLE 71 WHEELCHAIR TYPES AND PERCENT OF MARKET, 2007 (%)

MARKET DRIVERS

TABLE 72 PROJECTED U.S, MARKET FOR WHEELCHAIR/SCOOTER MOBILITY PRODUCTS FOR THE ELDERLY, THROUGH 2014 ($ MILLIONS)

Special Purpose Wheelchairs

MOTOR VEHICLE CONVERSIONS

NAVIGATION AIDS

Ultrasound Guidance Systems

GPS Systems

TABLE 73 SELECTED NAVIGATION AIDS MANUFACTURERS

ACCESS AIDS

MARKET FOR ACCESS AIDS

TABLE 74 PROJECTED U.S. SALES OF ACCESS AID PRODUCTS BY SEGMENT, THROUGH 2014 ($ MILLIONS)

TABLE 75 PROJECTED U.S. SALES OF ACCESS AID PRODUCTS FOR INDIVIDUALS OVER 65, BY SEGMENT, THROUGH 2014 ($ MILLIONS)

HOME ELEVATORS

WHEELCHAIR LIFTS

STAIR CLIMBERS

ACCESSIBLE BATHS AND SHOWERS

SPECIAL COMMODES

BATH AND POOL LIFTS

TRANSFER LIFTS

DOOR OPENERS

TABLE 76 SELECTED ACCESS AID MANUFACTURERS

OTHER AIDS

TABLE 77 SELECTED MANUFACTURERS OF BED, SEATING, AND ERGONOMIC AIDS FOR THE ELDERLY

TABLE 78 PROJECTED MARKET FOR BEDS, SEATING SYSTEMS, AND ERGONOMIC AIDS FOR INDIVIDUALS OVER 65, THROUGH 2014 ($ MILLIONS)

Beds, Seating

Bariatric Beds

Seating and Positioning Systems

Ergonomic Aids

TABLE 79 EXAMPLES HAVE ERGONOMIC AIDS FOR THE ELDERLY

Computer Access Aids

Input Devices

Output Devices

Computer Software

TABLE 80 SELECTED COMPUTER AID MANUFACTURERS

ENVIRONMENTAL AIDS

TABLE 81 SELECTED ENVIRONMENTAL AID MANUFACTURERS

ASSISTIVE TECHNOLOGIES UNDER DEVELOPMENT

ELECTRONICS

Mobile Location Technology

Sensor Technology

Artificial Intelligence

ENERGY SOURCES

MINIATURIZATION

CHAPTER NINE: COMPANY DIRECTORY

ABBOTT LABORATORIES

BUSINESS OVERVIEW

FINANCIALS

PRODUCTS

ASTRAZENECA PLC

BUSINESS OVERVIEW

FINANCIALS

PRODUCTS

BAY ADVANCED TECHNOLOGIES, LTD.

BUSINESS OVERVIEW

FINANCIALS

PRODUCTS

BAYER AG (MILES-BAYER)

BUSINESS OVERVIEW

FINANCIALS

PRODUCTS

BRISTOL-MYERS SQUIBB

BUSINESS OVERVIEW

FINANCIALS

PRODUCTS

BROOKDALE SENIOR LIVING

BUSINESS OVERVIEW

FINANCIALS

PRODUCTS

CENTOCOR

BUSINESS OVERVIEW

FINANCIALS

PRODUCTS

COVIDIEN

BUSINESS OVERVIEW

FINANCIALS

PRODUCTS

ELI LILLY

BUSINESS OVERVIEW

FINANCIALS

PRODUCTS

FOREST PHARMACEUTICALS

BUSINESS OVERVIEW

FINANCIALS

PRODUCTS

GENENTECH, INC.

BUSINESS OVERVIEW

FINANCIALS

PRODUCTS

GLAXOSMITHKLINE PLC

BUSINESS OVERVIEW

FINANCIALS

PRODUCTS

GRAHAM-FIELD HEALTH PRODUCTS

BUSINESS OVERVIEW

FINANCIALS

PRODUCTS

HONEYWELL HOMMED, LLC

BUSINESS OVERVIEW

FINANCIALS

PRODUCTS

HUMANWARE

FINANCIALS

PRODUCTS

INVACARE CORP.

BUSINESS OVERVIEW

FINANCIALS

PRODUCTS

JOHNSON & JOHNSON

BUSINESS OVERVIEW

FINANCIAL INFORMATION

PRODUCTS

KIMBERLY CLARK

BUSINESS OVERVIEW

FINANCIALS

PRODUCTS

KINDRED HEALTHCARE

BUSINESS OVERVIEW

FINANCIALS

PRODUCTS

LIFE ALERT EMERGENCY RESPONSE

BUSINESS OVERVIEW

FINANCIALS

PRODUCTS

LIFE CARE CENTERS OF AMERICA

BUSINESS OVERVIEW

FINANCIALS

PRODUCTS

LIFE GUARDIAN LLC

BUSINESS OVERVIEW

FINANCIALS

PRODUCTS

LIVHOME, INC.

BUSINESS OVERVIEW

FINANCIALS

PRODUCTS

HCR MANOR CARE

BUSINESS OVERVIEW

FINANCIALS

PRODUCTS

MAXHEALTH CORPORATON

BUSINESS OVERVIEW

FINANCIALS

PRODUCTS

MEDLINE INDUSTRIES, INC

BUSINESS OVERVIEW

FINANCIALS

PRODUCTS

MERCK & CO INC

BUSINESS OVERVIEW

FINANCIAL INFORMATION

PRODUCTS

NOVARTIS AG

BUSINESS OVERVIEW

FINANCIALS

PRODUCTS

NOVO NORDISK

BUSINESS OVERVIEW

FINANCIALS

PRODUCTS

OPTELEC

BUSINESS OVERVIEW

FINANCIALS

PRODUCTS

ORTHO-MCNEIL

BUSINESS OVERVIEW

FINANCIALS

PRODUCTS

PFIZER

BUSINESS OVERVIEW

FINANCIALS

PRODUCTS

PHILIPS LIFELINE SYSTEMS, INC.

BUSINESS OVERVIEW

FINANCIALS

PRODUCTS

PHONAK AG

BUSINESS OVERVIEW

FINANCIALS

PRODUCTS

PRIDE MOBILITY PRODUCTS CORP

BUSINESS OVERVIEW

FINANCIALS

PRODUCTS

ROCHE PHARMACEUTICALS

BUSINESS OVERVIEW

FINANCIALS

PRODUCTS

SANOFI-AVENTIS

BUSINESS OVERVIEW

FINANCIALS

PRODUCTS

SAVARIA CONCORD LIFTS, INC.

BUSINESS OVERIEW

FINANCIALS

PRODUCTS

SCA (SVENSKA CELLULOSA AKTIEBOLAGET)

BUSINESS OVERVIEW

FINANCIALS

PRODUCTS

SCHERING-PLOUGH

BUSINESS OVERVIEW

FINANCIALS

PRODUCTS

SIEMENS HEARING INSTRUMENTS, INC.

BUSINESS OVERVIEW

FINANCIALS

PRODUCTS

STARKEY LABORATORIES

BUSINESS OVERVIEW

FINANCIALS

PRODUCTS

SUNRISE MEDICAL, INC

BUSINESS OVERVIEW

FINANCIALS

PRODUCTS

SUNRISE SENIOR LIVING

BUSINESS OVERVIEW

FINANCIALS

PRODUCTS

TAKEDA PHARMACUETICALS

BUSINESS OVERVIEW

FINANCIALS

PRODUCTS

THORNDIKE PRESS

BUSINESS OVERVIEW

FINANCIALS

PRODUCTS

THYSSENKRUPP ACCESS

BUSINESS OVERVIEW

FINANCIALS

PRODUCTS

TYCO INTERNATIONAL

BUSINESS OVERVIEW

FINANCIALS

PRODUCTS

WIDEX

BUSINESS OVERVIEW

FINANCIALS

PRODUCTS

WYETH

BUSINESS OVERVIEW

FINANCIALS

PRODUCTS

APPENDIX

DEFINITIONS

ACTIVITIES OF DAILY LIVING (ADLS)

ALZHEIMER’S DISEASE

ARTHRITIS

ASSISTIVE TECHNOLOGY

ASSISTED LIVING

BABY BOOMER

CAREGIVERS

CARDIOVASCULAR DISEASE (CVD)

CONGESTIVE OBSTRUCTIVE PULMONARY DISEASE (COPD)

DEMENTIA

DIABETES

DURABLE MEDICAL EQUIPMENT

ELDER/SENIOR

GERONTOLOGY

HOSPICE CARE

INSTRUMENTAL ACTIVITIES OF DAILY LIVING (IADL)

LONG-TERM CARE

PROSTHETICS AND ORTHOTICS

LIST OF TABLES

SUMMARY TABLE PROJECTED NEEDS OF THE U.S. ELDERLY,

THROUGH 2014 ($ MILLIONS)

TABLE 1 ESTIMATES FOR OVER-65 POPULATIONS BY U.S. REGION,

2007

TABLE 2 MOST COMMON CHRONIC CONDITIONS BY AGE, GENDER,

AND RACE IN U.S., 2005

TABLE 3 COMPARISON OF ESTIMATED GOVERNMENT HEALTHCARE

SPENDING AS A PERCENT OF GDP, 2007 (%/$ MILLIONS))

TABLE 4 SELECTED PUBLIC AND PRIVATE PENSION

EXPENDITURES, 2006 ($ MILLIONS)

TABLE 5 CURRENT MEDICARE/MEDICAID PAYMENTS FOR

SERVICES, 2009

TABLE 6 PROJECTED U.S. MARKET FOR ELDERCARE HEALTHCARE

PRODUCTS AND SERVICES, THROUGH 2014 ($ MILLIONS)

TABLE 7 INCIDENCE OF DIAGNOSED ARTHRITIS CASES AND

CHRONIC JOINT SYMPTOMS IN THE U.S. BY AGE GROUP, 2006

(MILLION PERSONS)

TABLE 8 NEWER ANTICYTOKINE AGENTS FOR THE TREATMENT OF

RHEUMATOID ARTHRITIS

TABLE 9 PROJECTED U.S. MARKET FOR PHARMACEUTICAL

ARTHRITIS MEDICATIONS FOR INDIVIDUALS OVER 65, AT

MANUFACTURER’S COST, THROUGH 2014 ($ MILLIONS)

TABLE 10 SELECTED HEART DISEASE MEDICATIONS

TABLE 11 GLOBAL MARKET FOR CARDIOVASCULAR DISEASE

MEDICATIONS, THROUGH 2014 ($ MILLIONS)

TABLE 12 U.S. MARKET FOR CARDIOVASCULAR DISEASE

MEDICATIONS FOR THE ELDERLY, THROUGH 2014 ($ MILLIONS)

TABLE 13 U.S. MARKET FOR CARDIOVASCULAR SURGICAL

PROCEDURES FOR THE ELDERLY, THROUGH 2014 ($ MILLIONS)

TABLE 14 COMMON PRESCRIPTION MEDICATIONS TO TREAT

ALZHEIMER’S DISEASE

TABLE 15 PERCENTAGE OF PATIENTS WHO REPORT BEING

DEPRESSED, BY CHRONIC CONDITION (%)

TABLE 16 GLOBAL DIRECT AND INDIRECT COST OF DEPRESSION,

THROUGH 2014 ($ MILLIONS)

TABLE 17 SELECTED ANTIDEPRESSANT MEDICATIONS

TABLE 18 PROJECTED U.S. MARKET FOR DEMENTIA AND

DEPRESSION MEDICATIONS FOR THE ELDERLY, THROUGH 2014

($ MILLIONS)

TABLE 19 PROJECTED GLOBAL COSTS FOR CANCER TREATMENTS,

THROUGH 2014 ($ MILLIONS)

TABLE 20 PROJECTED U.S. MARKET FOR ALL TYPES OF CANCER

TREATMENTS FOR INDIVIDUALS OVER 65, THROUGH 2014

($MILLIONS)

TABLE 21 SELECTED DIABETIC ORAL AGENTS, BY TYPE, TRADE

NAME AND MANUFACTURER

TABLE 22 GLOBAL MARKET FOR DIABETIC ORAL AGENTS,

THROUGH 2014 ($ MILLIONS)

TABLE 23 U.S. MARKET FOR DIABETIC ORAL AGENTS FOR ADULTS

OLDER THAN 65, THROUGH 2014 ($ MILLIONS)

TABLE 24 INSULIN MARKET IN U.S. FOR INDIVIDUALS OVER 65,

THROUGH 2014 ($ MILLIONS)

TABLE 25 SELECTED LIST OF COMPANIES MARKETING GLUCOSE

MONITORING TESTS

TABLE 26 GLOBAL MARKET FOR BLOOD GLUCOSE MONITORING

DEVICES, THROUGH 2014 ($ MILLIONS)

TABLE 27 U.S. BLOOD GLUCOSE MONITORING MARKET THROUGH

2014 ($ MILLIONS)

TABLE 28 GLOBAL BLOOD GLUCOSE MONITORING MARKET FOR

INDIVIDUALS OLDER THAN 65, THROUGH 2014 ($ MILLIONS)

TABLE 29 U.S. BLOOD GLUCOSE MONITORING MARKET FOR

INDIVIDUALS OLDER THAN 65, THROUGH 2014 ($ MILLIONS)

TABLE 30 PREVALENCE OF AGE-RELATED EYE DISEASES, 2004 (%)

TABLE 31 PROJECTED U.S. EYEWEAR SALES, THROUGH 2014 ($

MILLIONS)

TABLE 32 PROJECTED U.S. EYEWEAR SALES FOR INDIVIDUALS

OVER 65, THROUGH 2014 ($ MILLIONS)

TABLE 33 PROJECTED COST OF CATARACT SURGERY FOR

INDIVIDUALS OVER 65, THROUGH 2014 ($ MILLIONS)

TABLE 34 SELECTED HEARING AID MANUFACTURERS

TABLE 35 REPORTED INCIDENCE OF HEARING PROBLEMS AMONG

U.S. ADULTS BY SEX/AGE GROUP, 2006 (%)

TABLE 36 PROJECTED U.S. MARKET FOR HEARING AIDS FOR

INDIVIDUALS OVER 65, AT RETAIL PRICING, THROUGH 2014 ($MILLIONS)*

TABLE 37 2007 VISION AND READING AIDS SALES

TABLE 38 PROJECTED TRENDS IN NUMBER OF U.S. TOTAL HIP AND

KNEE REPLACEMENTS, THROUGH 2014 (THOUSANDS OF

PROCEDURES)

TABLE 39 U.S. ORTHOPEDIC IMPLANT MARKET BY NUMBER AND

TYPE OF PROCEDURE, THROUGH 2014

TABLE 40 PROJECTED U.S. AND REST OF THE WORLD ORTHOPEDIC

IMPLANT MARKET GROWTH, THROUGH 2014 ($ MILLIONS)

TABLE 41 PROJECTED U.S. COSTS OF ORTHOPEDIC SURGERY FOR

INDIVIDUALS OVER 65, THROUGH 2014 ($ MILLIONS)

TABLE 42 GLOBAL ORTHOBIOLOGICS MARKET, BY PRODUCT,

THROUGH 2014 ($ MILLIONS)

TABLE 43 SELECTED LIST OF COMMON ALLERGY/ASTHMA

MEDICATIONS

TABLE 44 SELECTED LISTING OF INHALED CORTICOSTEROIDS

TABLE 45 GLOBAL COSTS FOR ASTHMA MEDICATIONS FOR

INDIVIDUALS OVER 65, THROUGH 2014 ($ MILLIONS)

TABLE 46 U.S. COSTS FOR ASTHMA MEDICATIONS FOR

INDIVIDUALS OVER 65, THROUGH 2014 ($ MILLIONS)

TABLE 47 PROJECTED COSTS OF HOME OXYGEN AND RESPIRATORY

SUPPLIES FOR INDIVIDUALS OVER 65, THROUGH 2014 ($

MILLIONS)

TABLE 48 PROJECTED MARKET FOR INCONTINENCE MEDICATIONS

FOR INDIVIDUALS OVER 65, THROUGH 2014 ($ MILLIONS)

TABLE 49 SELECTED MEDICATIONS FOR BPH

TABLE 50 PROJECTED U.S. MARKET FOR BPH MEDICATIONS FOR

INDIVIDUALS OVER 65, THROUGH 2014 ($ MILLIONS)

TABLE 51 GLOBAL MARKET FOR PRESCRIPTION WEIGHT LOSS

PRODUCTS THROUGH 2014 ($ MILLIONS)

TABLE 52 PROJECTED HOUSING MARKETS FOR SENIORS OVER 65,

THROUGH 2014 ($ MILLIONS)

TABLE 53 PROJECTED SPENDING ON HOME RENOVATION

PROJECTS BY INDIVIDUALS OVER 65, THROUGH 2014 ($

MILLIONS)

TABLE 54 AVERAGE ANNUAL COST OF HOME CARE SERVICES, 2008

($)

TABLE 55 PROJECTED MARKET FOR HOME CARE SERVICES,

THROUGH 2014 ($ MILLIONS)

TABLE 56 PROJECTED GROWTH OF ASSISTED-LIVING COSTS IN THE

U.S. FOR INDIVIDUALS OVER 65, THROUGH 2014 ($ MILLIONS)

TABLE 57 PROJECTED MARKET FOR SKILLED NURSING FACILITIES

FOR INDIVIDUALS OVER 65, THROUGH 2014 ($ MILLIONS)

TABLE 58 PROJECTED U.S. ASSISTIVE TECHNOLOGY SALES FOR

THE ELDERCARE MARKET, THROUGH 2014 ($ MILLIONS)

TABLE 59 SELECTED MEDICAL/PERSONAL MONITORING AID

MANUFACTURERS

TABLE 60 PROJECTED U.S. SALES OF MEDICAL/PERSONAL

MONITORING AIDS FOR INDIVIDUALS OVER 65, THROUGH 2014 ($

MILLIONS)

TABLE 61 SELECTED DAILY LIVING AIDS MANUFACTURERS

TABLE 62 PROJECTED U.S. SALES OF DAILY LIVING AIDS FOR

INDIVIDUALS OVER 65, THROUGH 2014 ($ MILLIONS)

TABLE 63 DAILY LIVING AIDS MANUFACTURERS, SALES AND

PERCENT OF MARKET, 2007 ($ MILLIONS/PERCENT)

TABLE 64 PROJECTED U.S. SALES OF INCONTINENCE AND OSTOMY

PRODUCTS, THROUGH 2014 ($ MILLIONS)

TABLE 65 PROJECTED U.S. SALES OF COMMODE AND SHOWER

CHAIRS TO INDIVIDUALS OVER 65, THROUGH 2014 ($ MILLIONS)

TABLE 66 REPORTED INCIDENCE OF IMPAIRED MOBLITY AND

DEXTERITY IN THE U.S. BY SEX/AGE GROUP, 2006 (%)

TABLE 67 PROJECTED U.S. MARKET FOR MOBILITY PRODUCTS FOR

INDIVIDUALS OVER 65, THROUGH 2014 ($ MILLIONS)

TABLE 68 SELECTED AMBULATORY AID MANUFACTURERS

TABLE 69 PROJECTED U.S. SALES OF AMBULATORY AIDS FOR

INDIVIDUALS OVER 65, THROUGH 2014 ($ MILLIONS)

TABLE 70 SELECTED LIST OF WHEELCHAIR AND SCOOTER

MANUFACTURERS

TABLE 71 WHEELCHAIR TYPES AND PERCENT OF MARKET, 2007 (%)

TABLE 72 PROJECTED U.S, MARKET FOR WHEELCHAIR/SCOOTER

MOBILITY PRODUCTS FOR THE ELDERLY, THROUGH 2014 ($

MILLIONS)

TABLE 73 SELECTED NAVIGATION AIDS MANUFACTURERS

TABLE 74 PROJECTED U.S. SALES OF ACCESS AID PRODUCTS BY

SEGMENT, THROUGH 2014 ($ MILLIONS)

TABLE 75 PROJECTED U.S. SALES OF ACCESS AID PRODUCTS FOR

INDIVIDUALS OVER 65, BY SEGMENT, THROUGH 2014 ($

MILLIONS)

TABLE 76 SELECTED ACCESS AID MANUFACTURERS

TABLE 77 SELECTED MANUFACTURERS OF BED, SEATING, AND

ERGONOMIC AIDS FOR THE ELDERLY

TABLE 78 PROJECTED MARKET FOR BEDS, SEATING SYSTEMS, AND

ERGONOMIC AIDS FOR INDIVIDUALS OVER 65, THROUGH 2014 ($

MILLIONS)

TABLE 79 EXAMPLES HAVE ERGONOMIC AIDS FOR THE ELDERLY

TABLE 80 SELECTED COMPUTER AID MANUFACTURERS

TABLE 81 SELECTED ENVIRONMENTAL AID MANUFACTURERS

LIST OF FIGURES

SUMMARY FIGURE PROJECTED NEEDS OF THE U.S. ELDERLY, BY

MARKET SEGMENT, 2008-2014 ($ MILLIONS)

FIGURE 1 DISTRIBUTION OF OVER-65 U.S POPULATION BY

RACE/ETHNICITY 2007 AND 2015 (%)

FIGURE 2 PREVALANCE OF CHRONIC CONDITIONS AMONG ADULTS

IN THE U.S. OVER 65 YEARS OF AGE, BY RACE AND ETHNICITY (%)

FIGURE 3 CHRONIC CONDITIONS IN U.S. POPULATION OVER 65,

2005 (%)

FIGURE 4 U.S. NATIONAL SPENDING ON LONG-TERM CARE, BY

PAYER, 2005 (%)

FIGURE 5 LEADING CAUSES OF U.S. DEATHS IN THOSE OVER 65,

2007 (%)

FIGURE 6 PROJECTED U.S. POPULATION OVER 65 BY 2050 (%)

FIGURE 7 RECIPIENTS OF SOCIAL SECURITY BENEFITS, 2006 (%)

FIGURE 8 FUTURE BURDEN OF ARTHRITIS FOR THOSE OVER 65 IN

THE U.S., BY GENDER, 2010-2030 (MILLIONS)

FIGURE 9 CAUSES OF DEMENTIA IN PEOPLE OVER 65 (%)

FIGURE 10 ESTIMATED NEW CASES OF CANCER IN THE U.S., 2008

(%)

FIGURE 11 U.S. MARKET FOR EYEGLASSES AND CONTACTS IN 2007

(%)

FIGURE 12 PROJECTED LIFETIME LONG-TERM CARE NEEDS FOR

INDIVIDUALS OVER 65 (%)

FIGURE 13 DAILY LIVING MARKET, BY SEGMENT AND TOTAL

PERCENT OF SALES, 2007 (%)

FIGURE 14 PERCENT OF TOTAL SALES FOR OTHER DAILY LIVING

AIDS, 2007 (%)

Abstract

• The U.S. eldercare market was worth $279.2 billion in 2008 and an estimated $316.9 billion in 2009. This should reach $447.4 billion in 2014, for a compound annual growth rate (CAGR) of 7.1%.
• The healthcare segment has the largest share of the market, worth $146.4 billion in 2008 and an estimated $172.2 billion in 2009. This should increase at a CAGR of 9.1% to reach $266.8 billion in 2014.
• The housing segment has the second-largest market share, generating $127.4 billion in 2008. This segment is expected to reach $138.7 billion in 2009 and $171.5 billion in 2014, for a CAGR of 4.3%.

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 720 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.